D
David C. Page
Researcher at Massachusetts Institute of Technology
Publications - 523
Citations - 47344
David C. Page is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Y chromosome & X chromosome. The author has an hindex of 110, co-authored 509 publications receiving 44119 citations. Previous affiliations of David C. Page include Hennepin County Medical Center & University of California, Los Angeles.
Papers
More filters
Patent
Stacked microlattice materials and fabrication processes
David C. Page,Sophia S. Yang,Alan J. Jacobsen,Zak C. Eckel,Christopher S. Roper,William B. Carter +5 more
TL;DR: In this article, a photomonomer resin is secured in a mold having a transparent bottom, the interior surface of which is coated with a mold-release agent, and a substrate is placed in contact with the top surface of the photomonomic resin.
Journal ArticleDOI
Word embedding mining for SARS-CoV-2 and COVID-19 drug repurposing
TL;DR: This work proposes a method of mining a large biomedical word embedding for FDA approved drugs based on drug-disease treatment analogies for COVID-19, and finds this approach promising and presents it to the computational drug repurposing community at large as another tool to help fight the pandemic.
Proceedings ArticleDOI
Generalized skewing for functions with continuous and nominal attributes
Soumya Ray,David C. Page +1 more
TL;DR: The results indicate that the algorithms extended to directly handle functions of continuous and nominal variables almost always outperforms an Information Gain-based decision tree learner.
Journal Article
A Monte Carlo study of randomised restarted search in ILP
TL;DR: In this paper, an empirical study of randomised restarted search in ILP problems was conducted and it was shown that the cutoff value is significantly more important than the specific refinement strategy, the starting element of the search, and the specific data domain.
Proceedings ArticleDOI
Quantifying predictive capability of electronic health records for the most harmful breast cancer.
Yirong Wu,Jun Fan,Peggy Peissig,Richard L. Berg,Ahmad P. Tafti,Jie Yin,Ming Yuan,David C. Page,Jennifer Cox,Elizabeth S. Burnside +9 more
TL;DR: EHR variables can be used to predict the “most harmful” breast cancer, providing the possibility to personalize care for those women at the highest risk in clinical practice.